The Asia Pacific Human Identification Market should witness market growth of 11.4% CAGR during the forecast period (2023-2030).
Increased technological advancements in human identification technology and multiple government programs and supports propel the market. These techniques are widely used in forensics for the identification of criminals. Key participants provide simplified, end-to-end forensic DNA analysis workflows to aid end users in resolving difficult cases and generating forensically investigative leads. They are committed to providing unrivaled service and continuous innovation to suit the demands of the present and the future.
The success of downstream analyses is highly correlated with the quantity and quality of genomic DNA recovered and purified from a forensic sample. To help end users solve challenging issues, the next-generation sequencing (NGS) system for HID collects additional information from complex samples.
The rapid implementation of a new, cutting-edge forensic science services facility assists in achieving their goal of providing forensic DNA testing in the community sooner. The assistance of application specialists is crucial in expediting the process and improving validation quality assurance, enabling the beginning of processing DNA evidence. It's expected that this development will encourage market growth.
Numerous initiatives by key market participants are propelling market expansion. For instance, the Centre of Excellence (CoE) for DNA Forensics in Gujrat, India, was created through collaboration between Thermo Fisher Scientific and the National Forensic Sciences University. Several initiatives implemented by governments and significant business entities are expected to make Asia Pacific the region with the quickest growth. For instance, the Chinese government declared that it would gather Tibetan genetic material to conduct widespread DNA testing. Such efforts have boosted the expansion of the market.
The China market dominated the Asia Pacific Human Identification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $236.6 million by 2030. The Japan market is estimated to grow at a CAGR of 10.7% during (2023-2030). Additionally, India's market would showcase a CAGR of 12% during (2023-2030).
Based on End-user, the market is segmented into Forensic Laboratories and Research Centers, Academic & Government Institutes. Based on Product, the market is segmented into Assay Kits and Reagents, Instruments and Others. Based on Application, the market is segmented into Forensic Applications, Paternity Identification and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction, Next-Generation Sequencing, Capillary Electrophoresis and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH
Increased technological advancements in human identification technology and multiple government programs and supports propel the market. These techniques are widely used in forensics for the identification of criminals. Key participants provide simplified, end-to-end forensic DNA analysis workflows to aid end users in resolving difficult cases and generating forensically investigative leads. They are committed to providing unrivaled service and continuous innovation to suit the demands of the present and the future.
The success of downstream analyses is highly correlated with the quantity and quality of genomic DNA recovered and purified from a forensic sample. To help end users solve challenging issues, the next-generation sequencing (NGS) system for HID collects additional information from complex samples.
The rapid implementation of a new, cutting-edge forensic science services facility assists in achieving their goal of providing forensic DNA testing in the community sooner. The assistance of application specialists is crucial in expediting the process and improving validation quality assurance, enabling the beginning of processing DNA evidence. It's expected that this development will encourage market growth.
Numerous initiatives by key market participants are propelling market expansion. For instance, the Centre of Excellence (CoE) for DNA Forensics in Gujrat, India, was created through collaboration between Thermo Fisher Scientific and the National Forensic Sciences University. Several initiatives implemented by governments and significant business entities are expected to make Asia Pacific the region with the quickest growth. For instance, the Chinese government declared that it would gather Tibetan genetic material to conduct widespread DNA testing. Such efforts have boosted the expansion of the market.
The China market dominated the Asia Pacific Human Identification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $236.6 million by 2030. The Japan market is estimated to grow at a CAGR of 10.7% during (2023-2030). Additionally, India's market would showcase a CAGR of 12% during (2023-2030).
Based on End-user, the market is segmented into Forensic Laboratories and Research Centers, Academic & Government Institutes. Based on Product, the market is segmented into Assay Kits and Reagents, Instruments and Others. Based on Application, the market is segmented into Forensic Applications, Paternity Identification and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction, Next-Generation Sequencing, Capillary Electrophoresis and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH
Scope of the Study
By End-user
- Forensic Laboratories
- Research Centers, Academic & Government Institutes
By Product
- Assay Kits and Reagents
- Instruments
- Others
By Application
- Forensic Applications
- Paternity Identification
- Others
By Technology
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Capillary Electrophoresis
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Hamilton Company
- Bio-Rad Laboratories, Inc
- Qiagen N.V
- SecuriGene Technologies Inc.
- AutoGen Inc.
- InnoGenomics Technologies, LLC.
- Carolina Biological Supply Company
- Genetek Biopharma GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Asia Pacific Human Identification Market by End User
Chapter 6. Asia Pacific Human Identification Market by Product
Chapter 7. Asia Pacific Human Identification Market by Application
Chapter 8. Asia Pacific Human Identification Market by Technology
Chapter 9. Asia Pacific Human Identification Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Hamilton Company
- Bio-Rad Laboratories, Inc
- Qiagen N.V
- SecuriGene Technologies Inc.
- AutoGen Inc.
- InnoGenomics Technologies, LLC.
- Carolina Biological Supply Company
- Genetek Biopharma GmbH
Methodology
LOADING...
